Serum amyloid A, fetuin-A, and pentraxin-3 levels in patients with ischemic stroke: Novel prognostic biomarkers?

Turkish Journal of Medical Sciences

Volumn 44, Issue 1, 2014, Pages 16-23

  Sezer, Sevilay ^a   Uçar, Fatma ^b   Ulusoy, Ersin Kasim ^a   Erdoǧan, Serpil ^a   Bilen, Şule ^a   Züngün, Cevdet ^a   Uysal, Sema ^a   Erdemli, Haci Kemal ^c  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b DISKAPI YILDIRIM BEYAZIT TRAINING AND RESEARCH HOSPITAL   (Turkey)

^c HITIT UNIVERSITY   (Turkey)

Author keywords

Acute ischemic stroke; Fetuin A; Pentraxin 3; Serum amyloid A

Indexed keywords

ALBUMIN; AMYLOID A PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FETUIN A; FIBRINOGEN; GLUCOSE; PENTRAXIN 3; SERUM AMYLOID A; SERUM AMYLOID P;

AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL FEATURE; COMORBIDITY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; SMOKING; ADULT; BLOOD; CEREBROVASCULAR ACCIDENT; MIDDLE AGED;

ADULT; AGED; ALPHA-2-HS-GLYCOPROTEIN; BRAIN ISCHEMIA; C-REACTIVE PROTEIN; FEMALE; HUMANS; MALE; MIDDLE AGED; SERUM AMYLOID A PROTEIN; SERUM AMYLOID P-COMPONENT; STROKE;

EID: 84888396019     PISSN: 13000144     EISSN: None     Source Type: Journal    
DOI: 10.3906/sag-1211-90     Document Type: Article

References (25)

1. Ormstad H, Aass HCD, Lund-Sorensen N, Amthor KF, Sandvik L. Serum levels of cytokines and C-reactive protein in acute ischemic stroke patients, and their relationship to stroke lateralization, type, and infarct volume. J Neurol 2011; 258: 677-685.
2. Ryu WS, Kim CK, Kim BJ, Kim C, Lee SH, Yoon BW. Pentraxin-3: a novel and independent prognostic marker in ischemic stroke. Atherosclerosis 2012; 220: 581-586.
3. Huang Y, Jing J, Zhao XQ, Wang CX, Wang YL, Liu GF, Wang CJ, Liu LP, Yang XM, Jiao Y et al. High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese. CNS Neurosci Ther 2012; 18: 261-266.
4. den Hertog HM, van den Herik EG, Dippel DW, Koudstaal PJ, de Maat MP. Variation in the C-reactive protein gene is associated with serum levels of CRP in patients with acute ischemic stroke. Cerebrovasc Dis 2010; 29: 372-375.
5. Song IU, Kim JS, Kim YI, Lee KS, Jeong DS, Chung SW. Relationship between high-sensitivity C-reactive protein and clinical functional outcome after acute ischemic stroke in a Korean population. Cerebrovasc Dis 2009; 28: 545-550.
6. Kunes P, Holubcova Z, Kolackova M, Krejsek J. Pentraxin-3 (PTX 3): an endogenous modulator of the inflammatory response. Mediators Inflamm 2012; 2012: 920517.
7. Latini R, Maggioni AP, Peri G, Gonzini L, Lucci D, Mocarelli P, Vago L, Pasqualini F, Signorini S, Soldateschi D et al. Prognostic significance of the long pentraxin PTX3 in acute myocardial infarction. Circulation 2004; 110: 2349-2354.
8. Weikert C, Stefan N, Schulze MB, Pischon T, Berger K, Joost HG, Haring HU, Boeing H, Fritsche A. Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke. Circulation 2008; 118: 2555-2562.
9. Tuttolomondo A, Di Raimondo D, Di Sciacca R, Casuccio A, Bivona G, Bellia C, Barreca L, Serio A, D'Aguanno G, Ciaccio M et al. Fetuin-A and CD40 L plasma levels in acute ischemic stroke: differences in relation to TOAST subtype and correlation with clinical and laboratory variables. Atherosclerosis 2010; 208: 290-296.
10. Brea D, Sobrino T, Blanco M, Fraga M, Agulla J, Rodriguez- Yanez M, Rodriguez-Gonzalez R, Perez de la Ossa N, Leira R, Forteza J et al. Usefulness of haptoglobin and serum amyloid A proteins as biomarkers for atherothrombotic ischemic stroke diagnosis confirmation. Atherosclerosis 2009; 205: 561-567.
11. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999; 265: 501-523.
12. Johnson BD, Kip KE, Marroquin OC, Ridker PM, Kelsey SF, Shaw LJ, Pepine CJ, Sharaf B, Bairey Merz CN, Sopko G et al. Serum amyloid A as a predictor of coronary artery disease and cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 2004; 109: 726-732.
13. Idicula TT, Waje-Andreassen U, Brogger J, Naess H, Thomassen L. Serum albumin in ischemic stroke patients: the higher the better. Cerebrovasc Dis 2009; 28: 13-17.
14. Chen PH, Gao S, Wang YJ, Xu AD, Li YS, Wang D. Classifying ischemic stroke, from TOAST to CISS. CNS Neurosci Ther 2012; 18: 452-456.
15. Sunnerhagen KS, Olver J, Francisco GE. Assessing and treating functional impairment in poststroke spasticity. Neurology 2013; 80: 35-44.
16. Somford DM, Marks MP, Thijs VN, Tong DC. Association of early CT abnormalities, infarct size, and apparent diffusion coefficient reduction in acute ischemic stroke. Am J Neuroradiol 2004; 25: 933-938.
17. Xu C, Yi C, Guo H, Liu Q, Wang L, Li H. Limb remote ischemic postconditioning is effective but also time-course-limited in protecting the brain from I/R injury. Turk J Med Sci 2012; 42: 918-929.
18. Vila N, Castillo J, Davalos A, Chamorro A. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke 2000; 31: 2325-2329.
19. Zeljkovic A, Vekic J, Spasojevic-Kalimanovska V, Jelic- Ivanovic Z, Bogavac-Stanojevic N, Gulan B, Spasic S. LDL and HDL subclasses in acute ischemic stroke: prediction of risk and short-term mortality. Atherosclerosis 2010; 210: 548-554.
20. Sut N, Celik Y. Prediction of mortality in stroke patients using multilayer perceptron neural networks. Turk J Med Sci 2012; 42: 886-893.
21. Jin R, Yang G, Li G. Inflammatory mechanisms in ischemic stroke: role of inflammatory cells. J Leukoc Biol 2010; 87: 779-789.
22. Kisialiou A, Pelone G, Carrizzo A, Grillea G, Trimarco V, Marino M, Bartolo M, De Nunzio AM, Grella R, Landolfi A et al. Blood biomarkers role in acute ischemic stroke patients: higher is worse or better? Immun Ageing 2012; 9: 22.
23. Kumar AD, Boehme AK, Siegler JE, Gillette M, Albright KC, Martin-Schild S. Leukocytosis in patients with neurologic deterioration after acute ischemic stroke is associated with poor outcomes. J Stroke Cerebrovasc Dis 2013; 22: e111-e117.
24. Rallidis LS, Vikelis M, Panagiotakos DB, Rizos I, Zolindaki MG, Kaliva K, Kremastinos DT. Inflammatory markers and inhospital mortality in acute ischaemic stroke. Atherosclerosis 2006; 189: 193-197.
25. den Hertog HM, van Rossum JA, van der Worp HB, van Gemert HM, de Jonge R, Koudstaal PJ, Dippel DW. C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death. J Neurol 2009; 256: 2003-2008.